계정 가입
이미 존재한 계정
가입을 클릭하여 코인타임의 <a class="underline" href="#term-of-service">서비스 약관</a> 과 a class="underline" href="#privacy-policy">개인정보 보호 정책</a> . 에 동의함.
email 로 로그인
email 로 가입
사용자 이메일
수신함을 확인하세요
중의 링크를 통해 로그인 하세요
중의 링크를 통해 가입 하세요
Amolyt Pharma
company
About
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders.
- 11 - 50
Details
- Last Funding Type
- Series Unknown
- Last Funding Money Raised
- €1.80M
- Industries
- Biotechnology,Health Care,Medical,Pharmaceutical,Therapeutics,Wellness
- Founded date
- Jan 1, 2007
- Number Of Employee
- 11 - 50
- Operating Status
- Active
Amolyt Pharma specializes in peptides for the treatment of rare endocrine and metabolic disorders. Its programs include AZP-3601, a parathyroid hormone analog, for the potential treatment of hypoparathyroidism, and AZP-3404, a peptide with a new and unique mechanism of action, that may restore fat and glucose metabolism.
Funding Rounds
Number of Funding Rounds
Total Funding Amount
3
€131.80M $80M
Amolyt Pharma has raised a total of
€131.80M $80M
in funding over 2 rounds. Their latest funding was raised on
Jan 6, 2023 from a Series C round.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 6, 2023 | Series C | €130M | 1 | — | — | Detail |
| Sep 16, 2021 | Series B | $80M | 1 | — | — | Detail |
| Mar 17, 2015 | Series Unknown | €1.80M | 1 | — | — | Detail |
Investors
Number of Lead Investors
Number of Investors
—
1
Amolyt Pharma is funded by 1 investors.
Credit Agricole Entreprises
are the most recent investors.
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Credit Agricole Entreprises
|
— | Series C |
Share
Twitter
LinkedIn
Line
Facebook
Telegram
Email
Page Link
